DekaBank Deutsche Girozentrale
LUMO

DekaBank Deutsche Girozentrale’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,378
Closed -$213K – 1053
2016
Q1 		$213K Sell
1,378
-244
-15% -$49.5K ﹤0.01% 842
2015
Q4 		$534K Buy
1,622
+22
+1% +$7.16K 0.01% 687
2015
Q3 		$516K Buy
1,600
+89
+6% +$39.1K 0.01% 685
2015
Q2 		$602K Buy
1,511
+50
+3% +$21.2K 0.01% 669
2015
Q1 		$719K Sell
1,461
-206
-12% -$79.8K 0.01% 630
2014
Q4 		$585K Sell
1,667
-144
-8% -$42.9K 0.01% 658
2014
Q3 		$349K Buy
1,811
+33
+2% +$7.25K ﹤0.01% 735
2014
Q2 		$425K Buy
1,778
+67
+4% +$13.6K 0.01% 635
2014
Q1 		$437K Buy
1,711
+89
+5% +$27.2K 0.01% 597
2013
Q4 		$333K Buy
1,622
+33
+2% +$5.87K 0.01% 600
2013
Q3 		$269K Buy
1,589
+167
+12% +$26.9K ﹤0.01% 620
2013
Q2 		$243K Buy
+1,422
New +$201K ﹤0.01% 509

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

DekaBank Deutsche Girozentrale's LUMO Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 1,378 shares — an estimated $213K sold.

DekaBank Deutsche Girozentrale first reported a position in LUMO in Q2 2013 and held it in 12 quarters. The position peaked at $719K in Q1 2015. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,378 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $213K.
  • DekaBank Deutsche Girozentrale first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
  • DekaBank Deutsche Girozentrale's Lumos Pharma, Inc. Common Stock position peaked at $719K in Q1 2015.
  • 112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.